Feline Hyperthyroidism: Treatment Options and Welfare Outcomes
Hyperthyroidism is the most common endocrine disease in older cats, causing weight loss, hyperactivity, and cardiac effects with several effective treatment options.
Key Facts
- Caused by benign adenomatous hyperplasia of thyroid tissue in most cases
- Signs include weight loss despite good appetite, vomiting, hyperactivity, and increased vocalization
- Four treatment options: medication, radioiodine, surgery, and dietary iodine restriction
- Radioiodine provides a curative single treatment with excellent welfare outcomes
- Treatment unmasks concurrent kidney disease — renal function must be assessed post-treatment
Welfare Considerations
Hyperthyroidism welfare management requires choosing among treatment options with different welfare profiles. Medical management with methimazole/carbimazole controls disease but requires lifelong daily administration and carries side effect risks. Radioiodine therapy provides definitive cure from a single outpatient treatment with minimal welfare burden beyond brief hospitalization for radiation isolation. Surgical thyroidectomy is effective but carries anesthetic risk in elderly cats. Dietary iodine restriction is non-invasive but requires strict adherence. All treatments carry the risk of unmasking subclinical kidney disease as blood flow normalizes post-treatment, requiring monitoring.
What You Can Do
- Discuss all four treatment options with your vet before deciding
- Consider radioiodine therapy as the welfare-optimal curative option where accessible
- Monitor kidney function carefully after any form of treatment
- If using medication, check for side effects including facial pruritus and blood count changes
- Schedule regular thyroid level monitoring to adjust medication dose as needed